HeartSciences Inc. (HSCSW) stock
HSCSWNasdaqFinance ServicesFiscal year ends April 30Also trades as HSCS
$0.07−0.03 (-30.62%)
Close on Oct 30, 2026Market cap $15.89MP/E –Yield 0.00%
HeartSciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
HeartSciences's revenue for the twelve months ending Jul 31, 2026 was $4.52K. For fiscal 2026 it was $4.32K, down 0.7% from the year before. The highest annual figure on record is $18.60K in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | $4.32K | -0.7% |
| FY2025 | Apr 30, 2025 | $4.35K | -76.6% |
| FY2024 | Apr 30, 2024 | $18.60K | +261.2% |
| FY2023 | Apr 30, 2023 | $5.15K | -64.2% |
| FY2022 | Apr 30, 2022 | $14.37K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027 | Jul 31, 2026 | $2.10K | +10.5% |
| Q4 FY2026 | Apr 30, 2026 | $0 | -100.0% |
| Q3 FY2026 | Jan 31, 2026 | $0 | – |
| Q2 FY2026 | Oct 31, 2025 | $2.42K | – |
| Q1 FY2026 | Jul 31, 2025 | $1.90K | -87.1% |
| Q4 FY2025 | Apr 30, 2025 | $4.35K | +11.5% |
| Q3 FY2025 | Jan 31, 2025 | $0 | – |
| Q4 FY2024 | Apr 30, 2024 | $0 | -100.0% |
| Q3 FY2024 | Jan 31, 2024 | $14.70K | – |
| Q2 FY2024 | Oct 31, 2023 | $3.90K | +21.9% |
| Q4 FY2023 | Apr 30, 2023 | $0 | -100.0% |
| Q3 FY2023 | Jan 31, 2023 | $1.95K | -28.8% |
| Q2 FY2023 | Oct 31, 2022 | $0 | – |
| Q1 FY2023 | Jul 31, 2022 | $3.20K | -57.2% |
| Q4 FY2022 | Apr 30, 2022 | $4.15K | – |
| Q3 FY2022 | Jan 31, 2022 | $2.74K | – |
| Q2 FY2022 | Oct 31, 2021 | $0 | – |
| Q1 FY2022 | Jul 31, 2021 | $7.48K | – |